FIELD: medicine; pharmacology.
SUBSTANCE: invention refers to medicine, particularly to pharmacology, and can be used to eliminate or prevent epileptic convulsions. Purpose of the invention is to search for new anticonvulsants among 7-oxycoumarin derivatives. Problem is solved using synthetic compound 7-(2-Morpholino-2-oxoethoxy)-2H-chromen-2-one.
EFFECT: in experiments on animals (mice) it is proved that the compound shows anticonvulsant activity, by 100 % protecting animals from death after LD50 nicotine introduction (14 mg/kg).
1 cl, 3 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| N-SUBSTITUTED (1S,4AR,5S)-METHYL-5-[2-(2'-OXO-2',5'-DIHYDRO1-H-PYRROL-3'-YL)ETHYL]-1,4A-DIMETHYL-6-METHYLENEDECAHYDRONAPHTHALENE-1-CARBOXYLATES HAVING ANTICONVULSANT ACTIVITY | 2008 |
|
RU2385863C2 |
| (1S,4a,5S,6R)-METHYL-5{2-[1-(2-AMINO-2-OXOETHYL)-2-OXOPYRROLIDIN-3-YL]ETHYL}-1,4a,6-TRIMETHYLDECAHYDRONAPHTHALENE-1-CARBOXYLATE, HAVING ANTICONVULSANT AND ANALGESIC ACTIVITY | 2008 |
|
RU2385864C2 |
| ANTICONVULSIVE MEDICATION | 2007 |
|
RU2355390C1 |
| N-ALKYL-TROPINES AND N-ALKYL-NORTROPINES HAVING h-LYTIC, ANTIPARKINSONIAN, ANTIEPILEPTIC, ANALGESIC AND ANTIDEPRESSANT ACTIVITY | 2014 |
|
RU2597616C2 |
| 3-BENZYLAMINOMETHYLENEPYRROLIDINE-2,4-DIONE AND ANTICONVULSANT AGENT BASED ON SAID | 1997 |
|
RU2144918C1 |
| ANTI-CONVULSIVE MEDICINE | 2008 |
|
RU2370260C1 |
| BENZOGONTATHIEPIN DERIVATIVE OF ANTICONVULSANT AND ANTIANXIOUS ACTIVITY | 2007 |
|
RU2341521C1 |
| 11-(4-TERT-BUTYLBENZYL)-2,3,4,5-TETRAHYDRO[1,3]DYAZEPINO[1,2-A]BENZIMIDAZOLE HYDROBROMIDE WITH ANXIOLYTIC AND ANTICONVULSANT ACTIVITY | 2017 |
|
RU2662242C1 |
| ANXIOLYTIC AGENT | 2017 |
|
RU2655929C1 |
| AMINOALKYL DERIVATIVES OF DIBENZOFURANONE OXIME EXHIBITING ANTICONVULSANT ACTIVITY | 2020 |
|
RU2773021C2 |
